Table of Content

1 Pertuzumab Market Overview
1.1 Product Overview and Scope of Pertuzumab
1.2 Pertuzumab Segment by Type
1.2.1 Global Pertuzumab Market Value Comparison by Type (2024-2034)
1.2.2 Human Source
1.2.3 Animal Source
1.3 Pertuzumab Segment by Application
1.3.1 Global Pertuzumab Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Medical Center
1.4 Global Pertuzumab Market Size Estimates and Forecasts
1.4.1 Global Pertuzumab Revenue 2018-2034
1.4.2 Global Pertuzumab Sales 2018-2034
1.4.3 Global Pertuzumab Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Pertuzumab Market Competition by Manufacturers
2.1 Global Pertuzumab Sales Market Share by Manufacturers (2018-2024)
2.2 Global Pertuzumab Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Pertuzumab Average Price by Manufacturers (2018-2024)
2.4 Global Pertuzumab Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Pertuzumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pertuzumab, Product Type & Application
2.7 Pertuzumab Market Competitive Situation and Trends
2.7.1 Pertuzumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pertuzumab Players Market Share by Revenue
2.7.3 Global Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pertuzumab Retrospective Market Scenario by Region
3.1 Global Pertuzumab Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Pertuzumab Global Pertuzumab Sales by Region: 2018-2034
3.2.1 Global Pertuzumab Sales by Region: 2018-2024
3.2.2 Global Pertuzumab Sales by Region: 2024-2034
3.3 Global Pertuzumab Global Pertuzumab Revenue by Region: 2018-2034
3.3.1 Global Pertuzumab Revenue by Region: 2018-2024
3.3.2 Global Pertuzumab Revenue by Region: 2024-2034
3.4 North America Pertuzumab Market Facts & Figures by Country
3.4.1 North America Pertuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Pertuzumab Sales by Country (2018-2034)
3.4.3 North America Pertuzumab Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pertuzumab Market Facts & Figures by Country
3.5.1 Europe Pertuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Pertuzumab Sales by Country (2018-2034)
3.5.3 Europe Pertuzumab Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pertuzumab Market Facts & Figures by Country
3.6.1 Asia Pacific Pertuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Pertuzumab Sales by Country (2018-2034)
3.6.3 Asia Pacific Pertuzumab Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pertuzumab Market Facts & Figures by Country
3.7.1 Latin America Pertuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Pertuzumab Sales by Country (2018-2034)
3.7.3 Latin America Pertuzumab Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pertuzumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Pertuzumab Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Pertuzumab Sales by Country (2018-2034)
3.8.3 Middle East and Africa Pertuzumab Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pertuzumab Sales by Type (2018-2034)
4.1.1 Global Pertuzumab Sales by Type (2018-2024)
4.1.2 Global Pertuzumab Sales by Type (2024-2034)
4.1.3 Global Pertuzumab Sales Market Share by Type (2018-2034)
4.2 Global Pertuzumab Revenue by Type (2018-2034)
4.2.1 Global Pertuzumab Revenue by Type (2018-2024)
4.2.2 Global Pertuzumab Revenue by Type (2024-2034)
4.2.3 Global Pertuzumab Revenue Market Share by Type (2018-2034)
4.3 Global Pertuzumab Price by Type (2018-2034)
5 Segment by Application
5.1 Global Pertuzumab Sales by Application (2018-2034)
5.1.1 Global Pertuzumab Sales by Application (2018-2024)
5.1.2 Global Pertuzumab Sales by Application (2024-2034)
5.1.3 Global Pertuzumab Sales Market Share by Application (2018-2034)
5.2 Global Pertuzumab Revenue by Application (2018-2034)
5.2.1 Global Pertuzumab Revenue by Application (2018-2024)
5.2.2 Global Pertuzumab Revenue by Application (2024-2034)
5.2.3 Global Pertuzumab Revenue Market Share by Application (2018-2034)
5.3 Global Pertuzumab Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Pertuzumab Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Novartis AG Pertuzumab Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Pertuzumab Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Pfizer Pertuzumab Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Abnova Corporation
6.3.1 Abnova Corporation Corporation Information
6.3.2 Abnova Corporation Description and Business Overview
6.3.3 Abnova Corporation Pertuzumab Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Abnova Corporation Pertuzumab Product Portfolio
6.3.5 Abnova Corporation Recent Developments/Updates
6.4 InvivoGen
6.4.1 InvivoGen Corporation Information
6.4.2 InvivoGen Description and Business Overview
6.4.3 InvivoGen Pertuzumab Sales, Revenue and Gross Margin (2018-2024)
6.4.4 InvivoGen Pertuzumab Product Portfolio
6.4.5 InvivoGen Recent Developments/Updates
6.5 Celltrion
6.5.1 Celltrion Corporation Information
6.5.2 Celltrion Description and Business Overview
6.5.3 Celltrion Pertuzumab Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Celltrion Pertuzumab Product Portfolio
6.5.5 Celltrion Recent Developments/Updates
6.6 Biocon Limited
6.6.1 Biocon Limited Corporation Information
6.6.2 Biocon Limited Description and Business Overview
6.6.3 Biocon Limited Pertuzumab Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Biocon Limited Pertuzumab Product Portfolio
6.6.5 Biocon Limited Recent Developments/Updates
6.7 Bio-Techne
6.6.1 Bio-Techne Corporation Information
6.6.2 Bio-Techne Description and Business Overview
6.6.3 Bio-Techne Pertuzumab Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Bio-Techne Pertuzumab Product Portfolio
6.7.5 Bio-Techne Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pertuzumab Industry Chain Analysis
7.2 Pertuzumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pertuzumab Production Mode & Process
7.4 Pertuzumab Sales and Marketing
7.4.1 Pertuzumab Sales Channels
7.4.2 Pertuzumab Distributors
7.5 Pertuzumab Customers
8 Pertuzumab Market Dynamics
8.1 Pertuzumab Industry Trends
8.2 Pertuzumab Market Drivers
8.3 Pertuzumab Market Challenges
8.4 Pertuzumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pertuzumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Pertuzumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Pertuzumab Market Competitive Situation by Manufacturers in 2022
Table 4. Global Pertuzumab Sales (MT) of Key Manufacturers (2018-2024)
Table 5. Global Pertuzumab Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Pertuzumab Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Pertuzumab Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Pertuzumab Average Price (USD/MT) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Pertuzumab, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Pertuzumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pertuzumab, Product Type & Application
Table 12. Global Key Manufacturers of Pertuzumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pertuzumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertuzumab as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pertuzumab Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Pertuzumab Sales by Region (2018-2024) & (MT)
Table 18. Global Pertuzumab Sales Market Share by Region (2018-2024)
Table 19. Global Pertuzumab Sales by Region (2024-2034) & (MT)
Table 20. Global Pertuzumab Sales Market Share by Region (2024-2034)
Table 21. Global Pertuzumab Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Pertuzumab Revenue Market Share by Region (2018-2024)
Table 23. Global Pertuzumab Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Pertuzumab Revenue Market Share by Region (2024-2034)
Table 25. North America Pertuzumab Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Pertuzumab Sales by Country (2018-2024) & (MT)
Table 27. North America Pertuzumab Sales by Country (2024-2034) & (MT)
Table 28. North America Pertuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Pertuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Pertuzumab Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Pertuzumab Sales by Country (2018-2024) & (MT)
Table 32. Europe Pertuzumab Sales by Country (2024-2034) & (MT)
Table 33. Europe Pertuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Pertuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Pertuzumab Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Pertuzumab Sales by Region (2018-2024) & (MT)
Table 37. Asia Pacific Pertuzumab Sales by Region (2024-2034) & (MT)
Table 38. Asia Pacific Pertuzumab Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Pertuzumab Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Pertuzumab Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Pertuzumab Sales by Country (2018-2024) & (MT)
Table 42. Latin America Pertuzumab Sales by Country (2024-2034) & (MT)
Table 43. Latin America Pertuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Pertuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Pertuzumab Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Pertuzumab Sales by Country (2018-2024) & (MT)
Table 47. Middle East & Africa Pertuzumab Sales by Country (2024-2034) & (MT)
Table 48. Middle East & Africa Pertuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Pertuzumab Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Pertuzumab Sales (MT) by Type (2018-2024)
Table 51. Global Pertuzumab Sales (MT) by Type (2024-2034)
Table 52. Global Pertuzumab Sales Market Share by Type (2018-2024)
Table 53. Global Pertuzumab Sales Market Share by Type (2024-2034)
Table 54. Global Pertuzumab Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Pertuzumab Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Pertuzumab Revenue Market Share by Type (2018-2024)
Table 57. Global Pertuzumab Revenue Market Share by Type (2024-2034)
Table 58. Global Pertuzumab Price (USD/MT) by Type (2018-2024)
Table 59. Global Pertuzumab Price (USD/MT) by Type (2024-2034)
Table 60. Global Pertuzumab Sales (MT) by Application (2018-2024)
Table 61. Global Pertuzumab Sales (MT) by Application (2024-2034)
Table 62. Global Pertuzumab Sales Market Share by Application (2018-2024)
Table 63. Global Pertuzumab Sales Market Share by Application (2024-2034)
Table 64. Global Pertuzumab Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Pertuzumab Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Pertuzumab Revenue Market Share by Application (2018-2024)
Table 67. Global Pertuzumab Revenue Market Share by Application (2024-2034)
Table 68. Global Pertuzumab Price (USD/MT) by Application (2018-2024)
Table 69. Global Pertuzumab Price (USD/MT) by Application (2024-2034)
Table 70. Novartis AG Corporation Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 73. Novartis AG Pertuzumab Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 78. Pfizer Pertuzumab Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Abnova Corporation Corporation Information
Table 81. Abnova Corporation Description and Business Overview
Table 82. Abnova Corporation Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 83. Abnova Corporation Pertuzumab Product
Table 84. Abnova Corporation Recent Developments/Updates
Table 85. InvivoGen Corporation Information
Table 86. InvivoGen Description and Business Overview
Table 87. InvivoGen Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 88. InvivoGen Pertuzumab Product
Table 89. InvivoGen Recent Developments/Updates
Table 90. Celltrion Corporation Information
Table 91. Celltrion Description and Business Overview
Table 92. Celltrion Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 93. Celltrion Pertuzumab Product
Table 94. Celltrion Recent Developments/Updates
Table 95. Biocon Limited Corporation Information
Table 96. Biocon Limited Description and Business Overview
Table 97. Biocon Limited Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 98. Biocon Limited Pertuzumab Product
Table 99. Biocon Limited Recent Developments/Updates
Table 100. Bio-Techne Corporation Information
Table 101. Bio-Techne Description and Business Overview
Table 102. Bio-Techne Pertuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 103. Bio-Techne Pertuzumab Product
Table 104. Bio-Techne Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Pertuzumab Distributors List
Table 108. Pertuzumab Customers List
Table 109. Pertuzumab Market Trends
Table 110. Pertuzumab Market Drivers
Table 111. Pertuzumab Market Challenges
Table 112. Pertuzumab Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pertuzumab
Figure 2. Global Pertuzumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Pertuzumab Market Share by Type in 2022 & 2034
Figure 4. Human Source Product Picture
Figure 5. Animal Source Product Picture
Figure 6. Global Pertuzumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Pertuzumab Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Medical Center
Figure 10. Global Pertuzumab Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 11. Global Pertuzumab Market Size (2018-2034) & (US$ Million)
Figure 12. Global Pertuzumab Sales (2018-2034) & (MT)
Figure 13. Global Pertuzumab Average Price (USD/MT) & (2018-2034)
Figure 14. Pertuzumab Report Years Considered
Figure 15. Pertuzumab Sales Share by Manufacturers in 2022
Figure 16. Global Pertuzumab Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Pertuzumab Players: Market Share by Revenue in 2022
Figure 18. Pertuzumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Pertuzumab Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 20. North America Pertuzumab Sales Market Share by Country (2018-2034)
Figure 21. North America Pertuzumab Revenue Market Share by Country (2018-2034)
Figure 22. U.S. Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Pertuzumab Sales Market Share by Country (2018-2034)
Figure 25. Europe Pertuzumab Revenue Market Share by Country (2018-2034)
Figure 26. Germany Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Pertuzumab Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Pertuzumab Revenue Market Share by Region (2018-2034)
Figure 33. China Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Taiwan Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Philippines Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Pertuzumab Sales Market Share by Country (2018-2034)
Figure 44. Latin America Pertuzumab Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Pertuzumab Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Pertuzumab Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. U.A.E Pertuzumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Pertuzumab by Type (2018-2034)
Figure 54. Global Revenue Market Share of Pertuzumab by Type (2018-2034)
Figure 55. Global Pertuzumab Price (USD/MT) by Type (2018-2034)
Figure 56. Global Sales Market Share of Pertuzumab by Application (2018-2034)
Figure 57. Global Revenue Market Share of Pertuzumab by Application (2018-2034)
Figure 58. Global Pertuzumab Price (USD/MT) by Application (2018-2034)
Figure 59. Pertuzumab Value Chain
Figure 60. Pertuzumab Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed